Literature DB >> 5276292

Hypoglycin A: a specific inhibitor of isovaleryl CoA dehydrogenase.

K Tanaka, E M Miller, K J Isselbacher.   

Abstract

Evidence is presented for the specific in vivo and in vitro inhibition of isovaleryl CoA dehydrogenation by hypoglycin A and its derivative, alpha-ketomethylenecyclopropylpropionic acid. alpha-Methylbutyryl CoA dehydrogenation was also impaired, but the degree of inhibition was much lower. Isobutyryl CoA dehydrogenation was not inhibited. 4-Pentenoic acid inhibited none of these reactions. It is concluded that isovaleryl CoA is dehydrogenated by a specific enzyme, isovaleryl CoA dehydrogenase, contrary to previous assumptions that it is dehydrogenated by green acyl CoA dehydrogenase. The present concept agrees with our previous findings in isovaleric acidemia, a genetic disorder in which a specific defect of isovaleryl CoA dehydrogenase was observed. It was also demonstrated that isovaleric acidemia can be induced in experimental animals by the administration of hypoglycin A. Furthermore, some symptoms of "the vomiting sickness of Jamaica" appear to be due to isovaleric acid accumulation secondary to the ingestion of hypoglycin A.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5276292      PMCID: PMC391092          DOI: 10.1073/pnas.68.1.20

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  METABOLISM AND METABOLIC EFFECTS OF HYPOGLYCIN.

Authors:  J CHANG; H BOEHM
Journal:  Biochim Biophys Acta       Date:  1964-09-04

2.  Hypoglycin A and B, two biologically active polypeptides from Blighia sapida.

Authors:  C H HASSALL; K REYLE
Journal:  Biochem J       Date:  1955-06       Impact factor: 3.857

3.  Enzymatic carboxylation of beta-hydroxyisovaleryl coenzyme A.

Authors:  B K BACHHAWAT; W G ROBINSON; M J COON
Journal:  J Biol Chem       Date:  1956-04       Impact factor: 5.157

4.  Neonatal death associated with isovalericacidaemia.

Authors:  C G Newman; B D Wilson; P Callaghan; L Young
Journal:  Lancet       Date:  1967-08-26       Impact factor: 79.321

5.  Effects of 4-pentenoic acid on carbohydrate metabolism in pigeon liver homogenate.

Authors:  C Corredor; K Brendel; R Bressler
Journal:  J Biol Chem       Date:  1969-03-10       Impact factor: 5.157

6.  Studies of the mechanism of the hypoglycemic action of 4-pentenoic acid.

Authors:  C Corredor; K Brendel; R Bressler
Journal:  Proc Natl Acad Sci U S A       Date:  1967-12       Impact factor: 11.205

7.  The isolation and identification of N-isovalerylglycine from urine of patients with isovaleric acidemia.

Authors:  K Tanaka; K J Isselbacher
Journal:  J Biol Chem       Date:  1967-06-25       Impact factor: 5.157

8.  Inhibition of the oxidation of leucine by hypoglycin.

Authors:  B I Posner; M S Raben
Journal:  Biochim Biophys Acta       Date:  1967-02-07

9.  The mechanism of action of hypoglycin on long-chain fatty acid oxidation.

Authors:  M Entman; R Bressler
Journal:  Mol Pharmacol       Date:  1967-07       Impact factor: 4.436

10.  Studies of the action of hypoglycin-A, an hypoglycaemic substance.

Authors:  P C FENG; S J PATRICK
Journal:  Br J Pharmacol Chemother       Date:  1958-06
View more
  6 in total

Review 1.  Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.

Authors:  Christopher T Walsh; Robert V O'Brien; Chaitan Khosla
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-31       Impact factor: 15.336

2.  Metabolism of [1-(14)C] and [2-(14)C] leucine in cultured skin fibroblasts from patients with isovaleric acidemia. Characterization of metabolic defects.

Authors:  K Tanaka; R Mandell; V E Shih
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II.

Authors:  N Gregersen; S Kølvraa; K Rasmussen; E Christensen; N J Brandt; F Ebbesen; F H Hansen
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

4.  Acylcarnitines profile best predicts survival in horses with atypical myopathy.

Authors:  François Boemer; Johann Detilleux; Christophe Cello; Hélène Amory; Christel Marcillaud-Pitel; Eric Richard; Gaby van Galen; Gunther van Loon; Laurence Lefère; Dominique-Marie Votion
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

5.  A new method for quantifying causative and diagnostic markers of methylenecyclopropylglycine poisoning.

Authors:  Johannes Sander; Michael Terhardt; Stefanie Sander; Sabine Aboling; Nils Janzen
Journal:  Toxicol Rep       Date:  2019-08-05

6.  The story of equine atypical myopathy: a review from the beginning to a possible end.

Authors:  Dominique-Marie Votion
Journal:  ISRN Vet Sci       Date:  2012-11-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.